{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:43:52Z","timestamp":1770723832462,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01094"],"award-info":[{"award-number":["PI14\/01094"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00657"],"award-info":[{"award-number":["PI17\/00657"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0025\/0017"],"award-info":[{"award-number":["RD16\/0025\/0017"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01094"],"award-info":[{"award-number":["PI14\/01094"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16CIII\/0002\/0002"],"award-info":[{"award-number":["RD16CIII\/0002\/0002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00657"],"award-info":[{"award-number":["PI17\/00657"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis E virus (HEV) has emerged as a relevant pathogen for HIV-infected patients. However, there is scarce data on HEV infection in HIV\/HCV-coinfected individuals with advanced fibrosis, which seems to increase the risk of HEV infection and worsen the prognosis of liver disease. We aimed to determine the prevalence of anti-HEV antibodies, acute hepatitis E, resolved hepatitis E, and exposure to HEV in HIV\/HCV-coinfected patients and to evaluate associations with clinical and epidemiological characteristics. We performed a cross-sectional study on 198 HIV\/HCV-coinfected patients, 30 healthy controls and 36 HIV-monoinfected patients. We found a low concordance between techniques used for detection of anti-HEV antibodies (ELISA versus Immunoblot), particularly in HIV\/HCV-coinfected patients. HIV\/HCV-coinfected patients showed the highest prevalence of IgG against HEV, resolved hepatitis E, and exposure to HEV (19.2%, 17.2%, and 22.2% respectively). However, we did not find any samples positive for HEV-RNA nor significant differences between groups. Moreover, HIV\/HCV-coinfected patients with CD4 T-cells &lt;350 cells\/mm<jats:sup>3<\/jats:sup> had higher prevalence for anti-HEV IgG antibodies, resolved hepatitis E, and exposure to HEV than healthy controls or those with CD4 T-cells\u2009\u2265\u2009350 cells\/mm<jats:sup>3<\/jats:sup> (<jats:italic>p<\/jats:italic>\u2009=\u20090.034, <jats:italic>p<\/jats:italic>\u2009=\u20090.035, and <jats:italic>p<\/jats:italic>\u2009=\u20090.053; respectively). In conclusion, HIV\/HCV-coinfected patients in Spain have a high prevalence for IgG anti-HEV antibodies, resolved hepatitis E, and exposure to HEV; particularly patients with CD4+T-cells &lt;350 cells\/mm<jats:sup>3<\/jats:sup>.<\/jats:p>","DOI":"10.1038\/s41598-018-37328-6","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T11:04:09Z","timestamp":1549278249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of hepatitis E infection in HIV\/HCV-coinfected patients in Spain (2012\u20132014)"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0977-741X","authenticated-orcid":false,"given":"Sonia","family":"V\u00e1zquez-Mor\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma \u00c1ngeles","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Canorea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Guardiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Quereda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Honta\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Avell\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-0450","authenticated-orcid":false,"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"37328_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/cmr.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar, N., Dalton, H. R., Abravanel, F. & Izopet, J. Hepatitis E virus infection. Clin Microbiol Rev 27, 116\u2013138, https:\/\/doi.org\/10.1128\/cmr.00057-13 (2014).","journal-title":"Clin Microbiol Rev"},{"key":"37328_CR2","unstructured":"WHO. Hepatitis E. (2017)."},{"key":"37328_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcv.2016.06.010","volume":"82","author":"C Adlhoch","year":"2016","unstructured":"Adlhoch, C. et al. Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014\/15. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 82, 9\u201316, https:\/\/doi.org\/10.1016\/j.jcv.2016.06.010 (2016).","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"key":"37328_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrgastro.2012.187","volume":"10","author":"R Aggarwal","year":"2013","unstructured":"Aggarwal, R. Diagnosis of hepatitis E. Nature reviews. Gastroenterology & hepatology 10, 24\u201333, https:\/\/doi.org\/10.1038\/nrgastro.2012.187 (2013).","journal-title":"Nature reviews. Gastroenterology & hepatology"},{"key":"37328_CR5","doi-asserted-by":"publisher","unstructured":"Hartl, J. et al. Hepatitis E Seroprevalence in Europe: A Meta-Analysis. Viruses 8, https:\/\/doi.org\/10.3390\/v8080211 (2016).","DOI":"10.3390\/v8080211"},{"key":"37328_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcv.2016.05.006","volume":"80","author":"JD Debes","year":"2016","unstructured":"Debes, J. D., Pisano, M. B., Lotto, M. & Re, V. Hepatitis E virus infection in the HIV-positive patient. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 80, 102\u2013106, https:\/\/doi.org\/10.1016\/j.jcv.2016.05.006 (2016).","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"key":"37328_CR7","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1111\/zph.12347","volume":"64","author":"A Rivero-Juarez","year":"2017","unstructured":"Rivero-Juarez, A. et al. Rural habitat as risk factor for hepatitis E virus seroconversion in HIV-infected patients: A prospective longitudinal study. Zoonoses Public Health 64, e60\u2013e64, https:\/\/doi.org\/10.1111\/zph.12347 (2017).","journal-title":"Zoonoses Public Health"},{"key":"37328_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jinf.2014.10.016","volume":"70","author":"A Rivero-Juarez","year":"2015","unstructured":"Rivero-Juarez, A. et al. High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients. The Journal of infection 70, 624\u2013630, https:\/\/doi.org\/10.1016\/j.jinf.2014.10.016 (2015).","journal-title":"The Journal of infection"},{"key":"37328_CR9","first-page":"314","volume":"28","author":"MF Lopez-Fabal","year":"2015","unstructured":"Lopez-Fabal, M. F. & Gomez-Garces, J. L. Seroprevalence of hepatitis E virus in patients with hepatitis C and\/or infected with HIV. Rev Esp Quimioter 28, 314\u2013316 (2015).","journal-title":"Rev Esp Quimioter"},{"key":"37328_CR10","doi-asserted-by":"publisher","first-page":"e103028","DOI":"10.1371\/journal.pone.0103028","volume":"9","author":"M Riveiro-Barciela","year":"2014","unstructured":"Riveiro-Barciela, M. et al. Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection. PloS one 9, e103028, https:\/\/doi.org\/10.1371\/journal.pone.0103028 (2014).","journal-title":"PloS one"},{"key":"37328_CR11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1097\/QAD.0000000000000378","volume":"28","author":"JA Pineda","year":"2014","unstructured":"Pineda, J. A. et al. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients. Aids 28, 1931\u20131937, https:\/\/doi.org\/10.1097\/QAD.0000000000000378 (2014).","journal-title":"Aids"},{"key":"37328_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jmv.23804","volume":"86","author":"ML Mateos-Lindemann","year":"2014","unstructured":"Mateos-Lindemann, M. L. et al. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. Journal of medical virology 86, 71\u201374, https:\/\/doi.org\/10.1002\/jmv.23804 (2014).","journal-title":"Journal of medical virology"},{"key":"37328_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1468-1293.2011.00985.x","volume":"13","author":"R Jardi","year":"2012","unstructured":"Jardi, R. et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV medicine 13, 379\u2013383, https:\/\/doi.org\/10.1111\/j.1468-1293.2011.00985.x (2012).","journal-title":"HIV medicine"},{"key":"37328_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","volume":"16","author":"L Platt","year":"2016","unstructured":"Platt, L. et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. The Lancet. Infectious diseases 16, 797\u2013808, https:\/\/doi.org\/10.1016\/S1473-3099(15)00485-5 (2016).","journal-title":"The Lancet. Infectious diseases"},{"key":"37328_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/QAD.0000000000001787","volume":"32","author":"LM Medrano","year":"2018","unstructured":"Medrano, L. M. et al. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV\/hepatitis C virus-coinfected patients. Aids 32, 1095\u20131105, https:\/\/doi.org\/10.1097\/QAD.0000000000001787 (2018).","journal-title":"Aids"},{"key":"37328_CR16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/QAD.0b013e32833a29ab","volume":"24","author":"C Renou","year":"2010","unstructured":"Renou, C. et al. Hepatitis E virus in HIV-infected patients. Aids 24, 1493\u20131499, https:\/\/doi.org\/10.1097\/QAD.0b013e32833a29ab (2010).","journal-title":"Aids"},{"key":"37328_CR17","unstructured":"WHO. Global Health sector strategy on Viral Hepatitis 2016\u20132021. Towards Ending Viral Hepatitis. (2016)."},{"key":"37328_CR18","unstructured":"ECDC. Hepatitis E in the EU\/EEA, 2005\u20132015. (2017)."},{"key":"37328_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jcv.2009.05.022","volume":"45","author":"M Fogeda","year":"2009","unstructured":"Fogeda, M., de Ory, F., Avellon, A. & Echevarria, J. M. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 45, 259\u2013261, https:\/\/doi.org\/10.1016\/j.jcv.2009.05.022 (2009).","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"key":"37328_CR20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jmv.23827","volume":"86","author":"C Hyams","year":"2014","unstructured":"Hyams, C. et al. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. Journal of medical virology 86, 478\u2013483, https:\/\/doi.org\/10.1002\/jmv.23827 (2014).","journal-title":"Journal of medical virology"},{"key":"37328_CR21","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1128\/CVI.00255-06","volume":"13","author":"M Buti","year":"2006","unstructured":"Buti, M. et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 13, 1328\u20131332, https:\/\/doi.org\/10.1128\/CVI.00255-06 (2006).","journal-title":"Clin Vaccine Immunol"},{"key":"37328_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/trf.12929","volume":"55","author":"S Sauleda","year":"2015","unstructured":"Sauleda, S. et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 55, 972\u2013979, https:\/\/doi.org\/10.1111\/trf.12929 (2015).","journal-title":"Transfusion"},{"key":"37328_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/jmv.25060","volume":"90","author":"S Zhou","year":"2018","unstructured":"Zhou, S. et al. Hepatitis E virus infection in HIV-infected patients: A large cohort study in Yunnan province, China. Journal of medical virology 90, 1121\u20131127, https:\/\/doi.org\/10.1002\/jmv.25060 (2018).","journal-title":"Journal of medical virology"},{"key":"37328_CR24","doi-asserted-by":"publisher","first-page":"e0160082","DOI":"10.1371\/journal.pone.0160082","volume":"11","author":"JD Debes","year":"2016","unstructured":"Debes, J. D. et al. Increased Hepatitis E Virus Seroprevalence Correlates with Lower CD4+ Cell Counts in HIV-Infected Persons in Argentina. PloS one 11, e0160082, https:\/\/doi.org\/10.1371\/journal.pone.0160082 (2016).","journal-title":"PloS one"},{"key":"37328_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3109\/23744235.2015.1049658","volume":"47","author":"G Scotto","year":"2015","unstructured":"Scotto, G. et al. Hepatitis E virus co-infection in HIV-infected patients in Foggia and Naples in southern Italy. Infect Dis (Lond) 47, 707\u2013713, https:\/\/doi.org\/10.3109\/23744235.2015.1049658 (2015).","journal-title":"Infect Dis (Lond)"},{"key":"37328_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7326\/0003-4819-138-8-200304150-00007","volume":"138","author":"FJ Palella Jr.","year":"2003","unstructured":"Palella, F. J. Jr. et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Annals of internal medicine 138, 620\u2013626 (2003).","journal-title":"Annals of internal medicine"},{"key":"37328_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/01.qai.0000247229.68246.c5","volume":"44","author":"B Lau","year":"2007","unstructured":"Lau, B., Gange, S. J. & Moore, R. D. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells\/mm3. Journal of acquired immune deficiency syndromes 44, 179\u2013187, https:\/\/doi.org\/10.1097\/01.qai.0000247229.68246.c5 (2007).","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"37328_CR28","doi-asserted-by":"crossref","unstructured":"Strategies for Management of Antiretroviral Therapy Study, G. et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. The Journal of infectious diseases 197, 1133\u20131144, 10.1086\/586713 (2008).","DOI":"10.1086\/586713"},{"key":"37328_CR29","doi-asserted-by":"publisher","unstructured":"When To Start, C. et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373, 1352\u20131363, https:\/\/doi.org\/10.1016\/S0140-6736(09)60612-7 (2009).","DOI":"10.1016\/S0140-6736(09)60612-7"},{"key":"37328_CR30","unstructured":"Dean, A., Sullivan, K. & Soe, M. OpenEpi: Open Source Epidemiologic Statistics for Public Health, http:\/\/www.openepi.com\/Menu\/OE_Menu.htm (2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37328-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:30:09Z","timestamp":1671255009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37328-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37328"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37328-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"5 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1143"}}